Construct validity and factor structure of survey-based assessment of cost-related medication burden

Medical Care

Volumn 53, Issue 2, 2015, Pages 199-206

  Burcu, Mehmet ^a   Alexander, G Caleb ^b   Ng, Xinyi ^a   Harrington, Donna ^c  

^a UNIVERSITY OF MARYLAND   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

Cost related medication burden; factor structure; Medicare; medication nonadherence; validity

Indexed keywords

ADULT; AGED; ARTICLE; BASIC NEEDS; COMMUNITY ASSESSMENT; CONSTRUCT VALIDITY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE SURVEY; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; MEDICARE; MEDICATION COMPLIANCE; PHARMACY; PRIORITY JOURNAL; COST OF ILLNESS; DRUG COST; MIDDLE AGED; SOCIOECONOMICS; STANDARDS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES; VALIDATION STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DRUG COSTS; FEMALE; HUMANS; MALE; MEDICARE; MEDICATION ADHERENCE; MIDDLE AGED; MODELS, ECONOMIC; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84922017231     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0000000000000286     Document Type: Article

References (50)

1. Heisler M, Choi H, Rosen AB, et al. Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis. Med Care. 2010;48:87-94.
2. Heisler M, Langa KM, Eby EL, et al. The health effects of restricting prescription medication use because of cost. Med Care. 2004;42:626-634.
3. Piette JD, Wagner TH, Potter MB, et al. Health insurance status, costrelated medication underuse, and outcomes among diabetes patients in three systems of care. Med Care. 2004;42:102-109.
4. Reed M, Brand R, Newhouse JP, et al. Coping with prescription Ddug cost sharing: knowledge, adherence, and financial burden. Health Serv Res. 2008;43:785-797.
5. Tseng CW, Tierney EF, Gerzoff RB, et al. Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study. Diabetes Care. 2008;31:261-266.
6. Wei II, Lloyd JT, Shrank WH. The relationship between the low-income subsidy and cost-related nonadherence to drug therapies in Medicare Part D. J Am Geriatr Soc. 2013;61:1315-1323.
7. Zivin K, Ratliff S, Heisler MM, et al. Factors influencing cost-related nonadherence to medication in older adults: a conceptually based approach. Value Health. 2010;13:338-345.
8. Madden JM, Graves AJ, Zhang F, et al. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA. 2008;299:1922-1928.
9. Zhang Y, Lave JR, Donohue JM, et al. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care. 2010;48:409-417.
10. Afendulis CC, He Y, Zaslavsky AM, et al. The impact of Medicare Part D on hospitalization rates. Health Serv Res. 2011;46:1022-1038.
11. Donohue JM, Zhang Y, Aiju M, et al. Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression. Am J Geriatr Psychiatr. 2011;19:989-997.
12. Elliott RA, Majumdar SR, Gillick MR, et al. Benefits and consequences for the poor and the disabled. N Engl J Med. 2005;353:2739-2741.
13. Stuart B, Simoni-Wastila L, Chauncey D. Assessing the impact of coverage gaps in the Medicare Part D drug benefit. Health Aff(Millwood). 2005;Suppl Web Exclusives:W5167-W5179.
14. Fung V, Mangione CM, Huang J, et al. Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes. Health Serv Res. 2010;45:355-375.
15. Li P, McElligott S, Bergquist H, et al. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia. Ann Intern Med. 2012;156:776-784.
16. Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004;27:384-391.
17. Piette JD, Heisler M, Horne R, et al. A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures. Soc Sci Med. 2006;62:846-857.
18. Heisler M, Wagner TH, Piette JD. Patient strategies to cope with high prescription medication costs: who is cutting back on necessities, increasing debt, or underusing medications? J Behav Med. 2005;28:43-51.
19. US Department of Health and Human Services; Centers for Medicare and Medicaid Services (CMS). Medicare Current Beneficiary Survey (MCBS). Available at: http://www.cms.gov/MCBS/. Accessed October 8, 2014.
20. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff (Millwood). 2005;Suppl Web Exclusives: W5152-W5166.
21. Soumerai SB, Pierre-Jacques M, Zhang F, et al. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med. 2006;166:1829-1835.
22. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: how well are states closing the gap? Health Aff (Millwood). 2002;Suppl Web Exclusives:W253-W268.
23. Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for costrelated medication nonadherence: a review of the literature. J Gen Intern Med. 2007;22:864-871.
24. Hanson KW, Neuman P, Dutwin D, et al. Uncovering the health challenges facing people with disabilities: the role of health insurance. Health Aff (Millwood). 2003;Suppl Web Exclusives: W3552-W3565.
25. Neuman P, Strollo MK, Guterman S, et al. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors. Health Aff (Millwood). 2007;26:w630-w643.
26. Spence MM, Hui R, Chan J. Cost reduction strategies used by elderly patients with chronic obstructive pulmonary disease to cope with a generic-only pharmacy benefit. J Manag Care Pharm. 2006;12:377-382.
27. Tseng CW, Brook RH, Keeler E, et al. Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA. 2004;292:952-960.
28. Gellad WF, Haas JS, Safran DG. Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med. 2007;22:1572-1578.
29. Nekhlyudov L, Madden J, Graves AJ, et al. Cost-related medication nonadherence and cost-saving strategies used by elderly Medicare cancer survivors. J Cancer Surviv. 2011;5:395-404.
30. Zivin K, Madden JM, Graves AJ, et al. Cost-related medication nonadherence among beneficiaries with depression following Medicare Part D. Am J Geriatr Psychiatry. 2009;17:1068-1076.
31. Kennedy JJ, Maciejewski M, Liu D, et al. Cost-related nonadherence in the Medicare program: the impact of Part D. Med Care. 2011;49:522-526.
32. Williams J, Steers WN, Ettner SL, et al. Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes. Med Care. 2013;51:193-198.
33. Pierre-Jacques M, Safran DG, Zhang F, et al. Reliability of new measures of cost-related medication nonadherence. Med Care. 2008;46:444-448.
34. Schmitt TA. Current methodological considerations in exploratory and confirmatory factor analysis. J Psychoeduc Assess. 2011;29:304-321.
35. Asparouhov T, Muthen BO. Weighted least squares estimation with missing data. 2010. Available at: http://www.statmodel.com/download/GstrucMissingRevision.pdf. Accessed October 8, 2014.
36. Kline RB. Principles and Practice of Structural Equation Modeling. New York, NY: Guilford Press; 2011.
37. Munn JC, Zimmerman S, Hanson LC, et al. Measuring the quality of dying in long-term care. J Am Geriatr Soc. 2007;55:1371-1379.
38. Park H, Barth RP, Harrington D. Factor structure of adoptive parentchild relationship items from the National Study of Adoptive Parents (NSAP). J Soc Social Work Res. 2013;4:20-30.
39. Salkind NJ. Encyclopedia of Research Design, Vol 1. Thousand Oaks, CA: SAGE; 2010.
40. Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct Equ Modeling. 1999;6:1-55.
41. Byrne BM. Structural Equation Modeling With Mplus: Basic Concepts, Applications, and Programming. New York, NY: Routledge; 2013.
42. US Department of Health and Human Services; Centers for Medicare and Medicaid Services (CMS). Closing the coverage gap-Medicare prescription drugs are becoming more affordable. Available at: http://www.medicare.gov/pubs/pdf/11493.pdf. Accessed October 8, 2014.
43. Kaiser Family Foundation. Cost containment strategies for prescription drugs: assessing the evidence in the literature. Available at: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id = 12175. Accessed October 8, 2014.
44. Berndt ER, Newhouse JP. Pricing and Reimbursement in US Pharmaceutical Markets. NBER Working Paper No. 16297; 2010.
45. Johnsrud M. Will a mandatory mail order pharmacy benefit save payers money? Academy of Managed Care Pharmacy Document, January 2006. Available at: http://www.amcp.org/WorkArea/DownloadAsset. aspx?id = 12192. Accessed October 8, 2014.
46. Bambauer KZ, Safran DG, Ross-Degnan D, et al. Depression and costrelated medication nonadherence in Medicare beneficiaries. Arch Gen Psychiatry. 2007;64:602-608.
47. Harrold LR, Briesacher BA, Peterson D, et al. Cost-related medication nonadherence in older patients with rheumatoid arthritis. J Rheumatol. 2013;40:137-143.
48. Alexander GC, Casalino LP, Meltzer DO. Patient-physician communication about out-of-pocket costs. JAMA. 2003;290:953-958.
49. Alexander GC, Casalino LP, Meltzer DO. Physician strategies to reduce patients' out-of-pocket prescription costs. Arch Intern Med. 2005;165: 633-636.
50. Alexander GC, Tseng CW. Six strategies to identify and assist patients burdened by out-of-pocket prescription costs. Cleve Clin J Med. 2004;71:433-437.